Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000712498 | SCV000232577 | uncertain significance | not provided | 2017-08-22 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000712498 | SCV000843000 | uncertain significance | not provided | 2018-05-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001826922 | SCV003447774 | uncertain significance | Cholestanol storage disease | 2022-10-17 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 448 of the CYP27A1 protein (p.Arg448His). This variant is present in population databases (rs370868184, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with CYP27A1-related conditions. ClinVar contains an entry for this variant (Variation ID: 198750). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CYP27A1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001826922 | SCV002078808 | uncertain significance | Cholestanol storage disease | 2020-01-31 | no assertion criteria provided | clinical testing |